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Background & aims: The aim of this study was to test how well the
Patient-Generated Subjective Global Assessment (PG-SGA) ques-
tion about food intake correlates with a well-established mea-
surement of food intake. Furthermore, we wanted to examine if
there were any associations between the patients ratings to the
question and weight change.
Methods: Data at baseline and after 4e6 weeks was drawn from
two studies which combined provided a sample of 85 patients
with lung and pancreatic cancer; one of the studies were an
intervention study, the other a prospective, observational study. All
patients completed the PG-SGA questionnaire, and rated their
food intake the past month as unchanged, increased or less than
usual. Energy and protein intake was estimated based upon a
24-h dietary recall.nt; PG-SGA, Patient Generated Subjective Global Assessment; KPS, Karnofsky
nts; WHO, World Health Organization.
e Research Centre (PRC), Department of Clinical and Molecular Medicine,
Norwegian University of Science and Technology, Trondheim, Norway.
lstad).
r Ltdonbehalfof EuropeanSociety forClinicalNutrition andMetabolism. This is
e (http://creativecommons.org/licenses/by-nc-nd/4.0/).
A. Bye et al. / Clinical Nutrition Experimental 25 (2019) 20e28 21Results: Patients reporting a food intake less than usual had a
lower energy (24.2 vs 30.3 kcal/kg/day, p ¼ 0.02) and protein (1.0
vs 1.2 g/kg/day, p ¼ 0.07) intake at baseline compared to patients
reporting unchanged or increased food intake. After comparison at
4e6 weeks, patients reporting a food intake less than usual, had a
lower energy (24.5 vs 31.7 kcal/kg/day, p ¼ 0.07) and protein (0.9
vs 1.3 g/kg/day, p ¼ 0.003) intake. Patients reporting a food intake
less than usual the past month lost more weight than patients with
an unchanged or increased intake (2.6 kg versus 0.7 kg respec-
tively, p < 0.001).
Conclusions: This study show that self-reported food intake
measured by PG-SGA corresponds to measured energy and protein
intake as well to weight change on a group level. This indicates
that patients self-report of food intake can be used as a valid
indication of food intake in patients with advanced cancer. Further
investigation of the psychometric properties of the question is
necessary to evaluate how well the question performs on an in-
dividual level.
© 2019 The Authors. Published by Elsevier Ltd on behalf of
European Society for Clinical Nutrition and Metabolism. This is an
open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Patients are the best sources of information about their own symptoms. This recognition is based on
several studies that show systematic underestimation of patient's frequency and severity of symptoms
by health care providers [1,2]. The use of patient reported outcome measures (PROMs) is therefore
highly recommended in both clinical practice and research [3]. In relation to nutrition in cancer, PROMs
are mainly used to provide information about weight change and symptoms that may cause reduced
food intake such as anorexia and nausea [4]. Despite strong recommendations in clinical guidelines on
nutrition in cancer [5], information on food intake is rarely collected. One of the main reasons for this is
probably demanding dietary assessment methods [6]. It is therefore a need for reliable and valid
PROMs that reﬂects actual food intake to simplify the collection of this important information.
The Patient-Generated Subjective Global Assessment (PG-SGA) is widely used to assess andmonitor
(risk for) malnutrition in cancer patients [7]. PG-SGA has been extensively validated and has shown
high degrees of ability to predict clinical outcomes such as shorter survival, postoperative complica-
tions and reduced tolerance to chemotherapy [8e12]. The ﬁrst part of PG-SGA is self-reported by the
patient and may be named a PROM [7,9,13]. It includes questions about current and former body
weight, the patient's appraisal of own food intake and current type of food/nutrient, nutritional impact
symptoms and activities and function [7]. Food intake is covered by the question: “As compared to
normal, I would rate my food intake during the past month as either unchanged, more than usual or
less than usual”.
To the best of our knowledge, the psychometric properties of the question regarding food intake is
not extensively evaluated. Although reliability and validity are essential psychometric properties for
any PROM [14], information about how well the question from PG-SGA correlates with well-
established measurements of food intake e so called criterion related validity e is lacking [14]. The
aim of this study was to evaluate correlation of self-reported food intake by PG-SGAwith actual energy
and protein intake measured with 24-h dietary recall in patients with advanced cancer. As a further
indicator of validity, we also aimed at evaluating the association between food intake by PG-SGA and
change in body weight after 4e6 weeks.
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2.1. Patients and study design
Data from two different studies were pooled; one multimodal intervention study and one pro-
spective observational study [15,16]. The multimodal intervention study was a multicentre, open,
randomized phase II study aiming to investigate the feasibility of a 6-weekmultimodal intervention for
patients with cachexia (ClinicalTrials.gov: NCT01419145) [15]. This study included 46 patients with
advanced pancreatic and lung cancer starting chemotherapy, and was conducted between 2011 and
2014. The intervention group received oral nutritional supplements (ONS), Celecoxib and physical
exercise, while the control group received standard cancer care. The main goal of the nutritional
intervention was to promote energy balance and ensure optimal protein intake [15].
The observational study investigated nutritional challenges in 39 patients with advanced
pancreatic cancer and was conducted at a single centre between 2006 and 2008 [16]. The patients
were recruited upon referral and monitored every fourth week. All patients received treatment with
palliative intent, including dietary counselling (increased meal frequency, energy dense foods and
ONS) whenever indicated. Enteral tube feeding or parenteral feeding were not initiated in any of the
studies.
2.2. Data collection
At baseline and after 4e6 weeks, patients were instructed to complete the PG-SGA in the inter-
vention study and SGA in the observational study. The question on self-reported food intake is “As
compared to normal, I would rate my food intake during the past month as: unchanged, more than
usual or less than usual”.
Energy and protein intake was assessed with 24-h dietary recall in both studies and performed by
trained study personnel [17]. Patients were asked to recall all food and beverage intake the previous
day from midnight to midnight, including ONS. Estimation of portion sizes was performed using a
photographic booklet and household measures with a supplementary list of household measurements
in weight. The collected information on dietary intake was analyzed by trained personnel using the
software Aivo 2000 (Aivo AB, Stockholm, Sweden) or Dietplan 6 Pro. The Norwegian food composition
tables were used as the nutrient database software program [18]. Energy and protein intake is pre-
sented as total daily intake (kcal/day) and as the total daily intake per kg body weight (kcal/kg/day).
Total energy intake per body weight was included due to the diverse patient group in terms of age and
gender, and in order to assess if the patients reporting less than usual are more likely to have an
inadequate energy intake and more likely to lose body weight. To evaluate predictive validity weight
change was used as a criterion. At baseline, self-reported weight change last 6 months was taken from
PG-SGA/SGA and actual bodyweight was assessed using an electronic scale in both studies and patients
were instructed to wear light clothes and no shoes at both baseline and after 4e6 weeks. Body mass
index (BMI) was measured from body weight (kg)/height (m2).
In the intervention study, the Karnofsky Performance Status (KPS) scale was used to evaluate
physical performance status, while the World Health Organization (WHO) performance status scale
was used in the observational study. The score of KPS from the intervention study was converted to the
WHO score using the recommended method for conversion [19].
2.3. Statistical analysis
Patient characteristics are presented using descriptive statistics. The categories of self-reported food
intake “unchanged” or “more than usual” were combined as one group in the analysis. Correlation
between PG-SGA food intake and actual energy intake, protein intake and change in body weight, were
assessed separately at baseline and at week 4e6. Student's t-test for independent samples was used to
compare means. The categories of self-reported food intake “unchanged” or “more than usual” were
combined as one group in the analysis. Simple linear regression models with actual energy intake,
protein intake and change in body weight as dependent variables were used to calculate variance
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24.0, 2016 (SPSS Inc, Chicago, IL, USA).3. Results
The baseline characteristics of the 85 included patients (38 females and 47 males) from the two
studies are summarized in Table 1. All patients had data on weight loss and SGA/PG-SGA at baseline,
while 83 (98%) had data on energy and protein intake. At 4e6 weeks, 67 (79%) patients had data on
body weight and SGA, 62 (73%) on energy and protein intake. All patients had a signiﬁcant reduction in
mean BMI, body weight andWHO performance status from baseline to after 4e6 week (p < 0.05 for all
variables) (Table 2).
Table 3 and Fig. 1 shows energy and protein intake at baseline and after 4e6 week comparing
patients reporting a food intake less than usual and unchanged or increased food intake. At baseline,
patients reporting a food intake less than usual had a lower energy and protein intake compared to
patients with an unchanged or increased food intake (p < 0.05 for all variables except for protein/kg/
day with p ¼ 0.07). At 4e6 weeks, patients reporting a food intake less than usual had a lower protein
intake (p < 0.05) and a lower but not statistically signiﬁcant (p ¼ 0.07) energy intake (kcal/kg/day).
Explained variation (R2) ranged from 0.06 to 0.14 for energy and protein intake at both time points
(Table 3).
At baseline, mean (SD) weight loss the last 6 months was 10.7 (7.8) % for the patients reporting an
intake less than usual and mean (SD) 6.9 (8.2) % for patients reporting an unchanged or increased foodTable 1
Baseline characteristics of the 85 patients.
Characteristics Value
Age, years, mean (SD) 60.8 (8.8)
Gender, female, n (%) 38 (44.7)
Diagnosis, n (%)
NSCLC stage III 5 (5.9)
NSCLC stage IV 21 (24.7)
Pancreatic cancer stage I-III 11 (12.9)
Pancreatic cancer stage IV 9 (10.6)
Locally unresectable pancreatic cancer 17 (20.0)
Metastatic pancreatic cancer 16 (18.8)
Recurrent disease after total pancreatic resection 6 (7.1)
Percentage weight loss last 6 months, mean (SD) 9.4 (8.1)
Weight loss last 6 months, n (%)
<5% 24 (28.2)
5e10% 24 (28.2)
>10% 37 (43.5)
NSCLC, Non-Small Cell Lung Cancer; n, number; SD, Standard Deviation.
Table 2
Nutritional and performance status at baseline and after 4e6 weeks.
Characteristics Baseline (n ¼ 85) 4e6 weeks (n ¼ 71)
BMI, mean (SD) 23.5 (3.8) 22.96 (3.9)
Weight (kg), mean (SD) 68.2 (13.0) 67.1 (12.8)
DWeight (kg), mean (SD) 0.7 (3.0)
WHO performance status, n (%)
0 20 (23.5) 11 (15.7)
1 56 (65.9) 41 (58.6)
2 9 (10.6) 17 (24.3)
3 0 (0.0) 1 (1.4)
n indicates number of individuals; BMI, Body Mass Index (measured as kg/m2); SD, Standard Deviation; WHO, World Health
Organization; D ¼ differences between baseline and 4e6 weeks.
Table 3
Energy and protein intake and weight change according to self-reported food intake at baseline and after 4e6 weeks.
Baselinea p R2 After 4e6 weeksb p R2
More than usual/
unchanged
(n ¼ 55)
Less than
usual
(n ¼ 28)
More than usual/
unchanged
(n ¼ 34)
Less than
usual
(n ¼ 28)
Energy intake (kcal/day) 2049 (785) 1572 (704) 0.006 0.09 2035 (898) 1702 (711) 0.11 0.04
Energy intake (kcal/kg/day) 30.3 (11.8) 24.2 (11.0) 0.02 0.06 31.7 (13.0) 24.5 (13.2) 0.07 0.06
Protein intake (g/day) 83.4 (37.8) 65.0 (33.1) 0.03 0.06 86.0 (37.8) 64.2 (31.9) 0.02 0.09
Protein intake (g/kg/day) 1.2 (0.5) 1.0 (0.5) 0.07 0.04 1.3 (0.55) 0.9 (0.48) 0.003 0.14
Weight change 6.9 (8.2) %c 10.7 (7.8) % 0.04 0.05 0.7 (2.2) kgd 2.6 (2.9) kg <0.001 0.30
a Student's t-test comparing categories at baseline.
b Student's t-test comparing categories after 4e6 weeks. R2 ¼ explained variance. Data shown as mean (SD).
c Weight loss in % last 6 months.
d DWeight in kg from baseline to 4e6 weeks.
Fig. 1. Box plots of Table 3. (A) Energy intake (kcal/kg) at baseline; (B) Protein intake (g/kg) at baseline; (C) Energy intake (kcal/kg)
at week 4e6; (D) Protein intake (g/kg) at week 4e6; (D) weight change from baseline to week 4e6 (kg). Number of patients equal to
Table 3. Red line indicates 30 kcal/kg for energy and 1 g/kg for protein.
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the past month had a mean (SD) decrease in body weight of 2.6 (2.9) kg compared to patients with an
unchanged or increased intake that increased their body weight by 0.7 (2.2) kg (p < 0.001) (Table 3 and
Fig. 1). Explained variation (R2) was 0.05 for weight change at baseline and 0.30 for weight change after
4e6 weeks (Table 3).
4. Discussion
In this study we found that self-reported food intake by PG-SGA was associated with energy and
protein intake measured by 24-h recall on a group level in patients with advanced cancer. We also
found associations between self-reported food intake and change in body weight both at baseline and
after 4e6 weeks.
To our knowledge, this is the ﬁrst study to validate the food intake question from PG-SGA by
comparing the question with established methods to measure energy and protein intake. Previously,
only one study has compared self-reported food intake to measured energy intake (using a 3-day food
diary) [20]. In this study food intake from PG-SGA was not used, but a similar scoring of food intake,
with the alternatives being normal, reduced or poor/minimal. Results from a small sub-group of 22
patients showed that a reduced or poor/minimal intakewas associated with lower energy (p¼ 0.04, no
effect size shown) and protein intake (p ¼ 0.003, no effect size shown) compared to self-reported
normal intake [20].
A statistical signiﬁcant ﬁnding does not in itself provide information about the clinical relevance of
research results. In the present study, we found that the difference between the group reporting eating
less than usual at baseline and the group reporting increased or unchanged food intake was approx-
imately 500 kcal/day. A difference of 500 kcal is quite large and would most likely be of clinical
relevance, as a rule of the thumb is that a deﬁcit of 500 kcal per day leads to a weight loss of
approximately 500 g in a week [21]. The clinical relevance of this ﬁnding is also conﬁrmed by a dif-
ference in weight change between the two groups at 4e6 weeks. The group of patients reporting food
intake less than usual at this time point had lost in average 2.6 kg with a high explained variance
R2 ¼ 0.30, which strengthens the validity of the PROM. The group reporting unchanged/increased food
intake had a stable weight and an average intake of 30.3 kcal/kg/day which is in accordance the
recommendation of intakes above 29 kcal/kg/day (120 kJ/kg/day) considered required for body
weight stabilization in cancer patients [22]. These ﬁndings help to substantiate the question as a
measure that can be used to provide information about food intake from the patients.
Evidence for an instrument's validity is not absolute, but falls along a continuum from “no evalu-
ation” to “full evaluation” for a given study population [23]. Thus, validity may therefore be described
as “continuous” rather than “dichotomous” psychometric indices. For this reason, claiming that an
instrument is completely “valid” is inaccurate. Similarly, saying an instrument has been “validated”
conveys no information other than to say its performance or psychometric properties have been
evaluated. Validation may be looked upon as a process and well-validated PROMs should have several
important properties as they are increasingly used in clinical decision-making, clinical research and
approval of new therapies [24]. In this studywe have demonstrated that the question performwell on a
group level but further validation studies are necessary to evaluate how well it performs on an indi-
vidual level.
In the present study we used the 24-h dietary recall as a criterion when evaluating the validity. It
could be argued that a criterion that covers just one day is not comparablewith PG-SGA question that is
supposed to cover the last month. However, studies investigating psychometric properties of different
PROMs have shown a high degree of correlation between patient ratings covering 24 h and longer
rating periods [25]. One explanation is that the condition in question does not change much over time
or that the patient's answer tends to reﬂect the most recent period. One other objection to using 24-
h dietary recall is that records of food intake for a single day are not representative of a person's usual
intake due to day-to-day variation [25]. However, our prospective design in both studies disclosed a
high degree of monotony in the individual patient's food choice [16]. In addition, both the 24-h recall
method and the question about food intake from PG-SGA are retrospective methods with the same
methodological ﬂaws, e.g. gaps and distortions in the memories of intake. Prospective methods of food
A. Bye et al. / Clinical Nutrition Experimental 25 (2019) 20e2826intake (3e7 days food diaries) would cover a longer time period and theoretically be a better criterion
method [26]. Nevertheless, dietary records tend to be less accurate over time, and due to the concern
for poor registration compliance in this frail patient population with advanced cancer, 24-h dietary
recall was chosen. The advantages of using the 24-h dietary recall is that it usually has a high
respondent rate and respondent burden is fairly lowas the time used to complete the interview is short
(around 20 min) [27]. A disadvantage is that 24-h dietary recalls reﬂect intake only on a group level
[17], which was in accordance with our observations with low explained variance and large variations
within groups. Self-reported food intake can therefore not replace acknowledge food registration
methods in cases where more information is needed as mentioned above.
The patients' interpretation of the question “As compared to normal, I would rate my food intake
during the past month as either unchanged, more than usual or less than usual” can vary considerably. The
perception of the words “normal” and “usual” food intake can be affected by whether patients' have
had a reduced food intake over a longer period, and that food intake could rapidly change during a
month. However, even with a substantial variation in energy and protein intake at both time points in
this study, there was a signiﬁcant difference between the groups, justifying further studies exploring
this simple question in order to reduce patient burden and prompt implementation of assessments of
nutritional intake in clinical studies. We encourage others to validate this question further and in other
populations as well.5. Conclusion
This study demonstrates an association between self-reported food intake from SGA/PG-SGA and
energy and protein intake measured from 24-h dietary recall on a group level. This association was
supported by weight loss in the group reporting food intake less than usual and stable weight in the
group reporting unchanged/increased food intake. This validation is of clinical relevance since the
question regarding food intake is a PROM that can easily be implemented into clinical studies. Using a
PROM to collect info about food intake would also minimize the burden of time consuming assess-
ments, which is of importance in patients with advanced cancer.Statement of authorship
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